VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 189 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.80 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $322 | -99.9% | 43,517 | -1.3% | 0.04% | -27.4% |
| Q3 2022 | $436,000 | -9.2% | 44,082 | 0.0% | 0.06% | -3.1% |
| Q2 2022 | $480,000 | -3.8% | 44,082 | 0.0% | 0.06% | +23.1% |
| Q1 2022 | $499,000 | -27.9% | 44,082 | 0.0% | 0.05% | -17.5% |
| Q4 2021 | $692,000 | -8.5% | 44,082 | 0.0% | 0.06% | -10.0% |
| Q3 2021 | $756,000 | -20.3% | 44,082 | 0.0% | 0.07% | -13.6% |
| Q2 2021 | $948,000 | +43.2% | 44,082 | 0.0% | 0.08% | +35.0% |
| Q1 2021 | $662,000 | +155.6% | 44,082 | +123.7% | 0.06% | +160.9% |
| Q4 2020 | $259,000 | +36.3% | 19,710 | +0.1% | 0.02% | +27.8% |
| Q3 2020 | $190,000 | -15.6% | 19,685 | 0.0% | 0.02% | -14.3% |
| Q2 2020 | $225,000 | +19.7% | 19,685 | +8.3% | 0.02% | +10.5% |
| Q1 2020 | $188,000 | -82.6% | 18,180 | -56.1% | 0.02% | -71.6% |
| Q4 2018 | $1,082,000 | – | 41,400 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 2,491,200 | $27,154,000 | 2.37% |
| Profit Investment Management, LLC | 281,890 | $3,071,000 | 2.26% |
| Sio Capital Management, LLC | 488,965 | $5,330,000 | 2.00% |
| Zebra Capital Management LLC | 14,766 | $161,000 | 0.47% |
| Prairiewood Capital, LLC | 50,165 | $547,000 | 0.43% |
| TANG CAPITAL MANAGEMENT LLC | 256,696 | $2,798,000 | 0.42% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $1,700,000 | 0.29% |
| GLOBEFLEX CAPITAL L P | 100,843 | $1,099,000 | 0.27% |
| Epoch Investment Partners, Inc. | 2,757,646 | $30,059,000 | 0.18% |
| EMC Capital Management | 16,185 | $176,000 | 0.15% |